Event Format

Webinar

Date

Fri, Apr 24, 2026, 01:00 PM CDT – Fri, Apr 24, 2026, 02:00 PM CDT

Cost

Members: Free | Non-Members: Free

Type

Webinars

Event Host

Contact Information

312-422-3860

Open To

Members and Non-members

Description

Event Schedule by Time Zone: 
Pacific: 11 AM to 12 PM | Mountain: 12 PM to 1 PM | Central: 1 PM to 2 PM | Eastern: 2 PM to 3 PM

Biofilms cause over 80% of microbial infections and are major contributors to healthcare-associated infections and antimicrobial resistance. This webinar merges scientific insights on biofilm biology with proven hospital strategies for detection, prevention, and control. Participants will learn how biofilms form on surfaces and medical devices, and why they resist antibiotics and disinfectants. You'll discover practical tools and protocols that work in healthcare settings. Leave with actionable steps for rapid detection, mechanical removal, monitoring, device management, drain protocols, risk assessment, and staff training.

Learning Objectives:

  1. Describe the structure, development stages, and key resistance mechanisms of both wet and dry surface biofilms, including the role of quorum sensing and the EPS matrix.
  2. Identify the three major biofilm reservoirs in healthcare facilities (drains, dry high-touch surfaces, and indwelling medical devices) and their contribution to HAIs and antimicrobial resistance.
  3. Select and apply appropriate detection methods for hospital settings, including rapid in-situ tools (BioTorch™), ATP, and protein residue testing to find invisible contamination.
  4. Implement a multi-layered biofilm prevention and control program that combines mechanical removal (microfiber + surfactants), oxidizing disinfectants (HOCl), thorough drying, water system management, and device handling protocols. 5. Conduct a practical biofilm risk assessment, link environmental findings to infection data, and design ongoing staff education and surveillance programs that measurably reduce HAI risk.
AHE CEC1

Speakers:

David W. Koenig, PhD is an internationally recognized leader in environmental services optimization and infection prevention, founder of DKMicrobios, and a principal architect of the DICE methodology. He combines clinical insight, forensic detection techniques, and practical EVS system design to help healthcare organizations standardize cleaning verification and reduce cross contamination risk. David’s work centers on translating forensic light detection, targeted sampling, and verification metrics into actionable EVS protocols that improve patient safety and operational consistency. Dr. Koenig has authored 62 book chapters/manuscripts and holds 90 US patents. He received his BS from Bowling Green State University, MS from University of Mississippi, and PhD from Louisiana State University.

Member: $0.00
Non-Member: $0.00

Sponsored By